PubMed · 2010 · 16 citations · 9 references
EngineeringBiotechnologyCardiologyCell TherapyRegenerative MedicineStem Cell BiologyAngiogenesisCardiac RegenerationMesenchymal Stem Cell TherapyTissue Engineering With Stem CellsVascular RegenerationVascularization StrategiesBone Marrow - Derived CellsBone Marrow Mesenchymal Stem CellsBone Marrow Stem Cell InfusionBone Marrow-derived Mesenchymal Stromal CellsCombination Cell TherapyEndothelial Progenitor CellsPreclinical-to-clinical TranslationProgenitor Cells
BACKGROUND: Infusion of diverse types of bone marrow cells, as a source of endothelial progenitor cells (EPCs), into the ischemic myocardium is emerging as a promising therapy for coronary ischemia, probably mediated by the formation of new blood vessels. Studies have shown that while the procedure is safe and feasible, efficacy results are contentious. The investigators in the present preclinical translation study hypothesized that the infusion of a combination cell product consisting of EPCs and other cell types, such as mesenchymal stem cells, promotes the formation of more stable and mature blood vessels resulting in improved clinical outcomes. The safety and feasibility of the intracoronary infusion of such a cell combination was assessed in a canine model. METHODS: A mixture of canine autologous mononuclear cells (as the source of EPCs) and ex vivo-expanded bone marrow-derived mesenchymal stem cells or a placebo solution were intracoronarily infused into healthy dogs. Follow-up after cell/placebo infusion included an electrocardiogram, serum cardiac enzyme testing, a transthoracic echocardiography and a histopathological heart examination. RESULTS: On follow-up at all time points after infusion, no significant changes or abnormalities in vital signs, electrocardiogram, transthoracic echocardiography and heart histology were detected. CONCLUSIONS: From a clinical perspective, the safety and feasibility of the protocol used in the present animal study demonstrated clinical relevance and provided direct evidence supporting the intracoronary infusion of combination stem/progenitor cell products.
9
Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction
Ketil Lunde, Svein Solheim, Svend Aakhus et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text
Medicine, Cardiology, Cell Therapy +11
Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium
Michael Hofmann, Kai C. Wollert, Gerd Peter Meyer et al. · Circulation · 2005 · 933 citations · Full text
Medicine, Cardiology, Cell Biology +14
William E. Shell, John Kjekshus, Burton E. Sobel · Journal of Clinical Investigation · 1971 · 521 citations · Full text